Cancer Incidence Rates in 2021 Indicate Return to Prepandemic Levels
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 30, 2024 -- The overall incidence rates for all cancer sites and specific cancer sites returned to prepandemic levels in 2021, according to a study published online Sept. 24 in the Journal of the National Cancer Institute.
Nadia Howlader, Ph.D., from the National Cancer Institute in Rockville, Maryland, and colleagues used 2021 incidence data from the Surveillance, Epidemiology, and End Results program to assess the impact of the pandemic on cancer incidence rates in the United States. Observed 2021 cancer incidence rates were compared to expected prepandemic trends, assessed by individual cancer site (breast, prostate, lung and bronchus, pancreas, and thyroid) and stage.
The researchers found that incidence overall and in many cancer sites was close to prepandemic levels, but there was no recovery that incorporated delayed diagnoses from 2020. Exceptions were seen, such as metastatic breast cancer, which had a significantly higher rate than expected (rate ratio, 1.09).
"Overall incidence rates for all cancer sites and the five specific cancer sites examined in this study returned to prepandemic levels. They did not, however, display a rebound to account for potential delayed diagnoses in 2020," the authors write. "Continuous monitoring is necessary to address the long-term consequences of the COVID-19 pandemic on cancer incidence and outcomes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Further Support and Information on COVID-19
Read this next
Helping Others Linked to Higher Level of Cognitive Function
THURSDAY, Aug. 21, 2025 -- Helping others, both via formal volunteering and informal helping, is associated with higher levels of cognitive function and slower cognitive decline...
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
THURSDAY, Aug. 21, 2025 -- For patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC), an intravesical...
Work-Related Income Drops for Parents of Children Diagnosed With Type 1 Diabetes
THURSDAY, Aug. 21, 2025 -- Work-related income decreases sharply for mothers and fathers of children diagnosed with type 1 diabetes, with similar effects across sociodemographic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.